The European organization for research and treatment of cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology

Journal of the National Cancer Institute

Volumn 85, Issue 5, 1993, Pages 365-376

  Aaronson, Neil K ^a   Ahmedzai, Sam ^b   Bergman, Bengt ^c   Bullinger, Monika ^d   Cull, Ann ^e   Duez, Nicole J ^f   Filiberti, Antonio ^g   Flechtner, Henning ^h   Fleishman, Stewart B ⁱ   Haes, Johanna C J M De ^j   Kaasa, Stein ^k   Klee, Marianne ^b   Osoba, David ^l   Razavi, Darius ^m   Rofe, Peter B ⁿ   Schraub, Simon ^a   Sneeuw, Kommer ^a   Sullivan, Marianne ^o   Takeda, Fumikazu ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b The Leicestershire Hospice ^*

^c Renströmska Hospital   (Sweden)

^d Biometric Center for Therapeutic Studies   (Germany)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f EORTC DATA CENTER   (Belgium)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h UNIVERSITY OF COLOGNE   (Germany)

ⁱ LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^j UNIVERSITY OF AMSTERDAM   (Netherlands)

^k OSLO UNIVERSITY HOSPITAL   (Norway)

^l JULES BORDET INSTITUTE   (Belgium)

^m ROYAL ADELAIDE HOSPITAL   (Australia)

ⁿ UNIVERSITY HOSPITAL OF BESANÇON   (France)

^o SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RESEARCH; DEMOGRAPHY; EUROPE; FEMALE; FUNCTIONAL ASSESSMENT; HEALTH CARE ORGANIZATION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; QUALITY OF LIFE; SCORING SYSTEM;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CLINICAL TRIALS; FEMALE; HEALTH STATUS; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; QUALITY OF LIFE; QUESTIONNAIRES; REPRODUCIBILITY OF RESULTS;

EID: 0027417437     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/85.5.365     Document Type: Article

References (59)

1. Moinpour CM, Feiol P, Metch B, et al: Quality of life end points in cancer clinical trials: Review and recommendations. J Natl Cancer Inst 81:485-495, 1989
2. Kornbuth AB, Anderson J, Cella DF, et al: Quality of life assessment of Hodgkin’s disease survivors: A model for cooperative clinical trials. Oncology (Williston Park) 4:93-101, 1990.
3. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index—Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630633, 1988
4. Osoba D: The Quality of Life Committee of the Clinical Trials Group of the National Cancer Institute of Canada: Organization and functions. Quality of Life Res 1:203-211, 1992
5. Aaronson NK, Beckmann J, eds: The Quality of Life of Cancer Patients. EORTC Mongraph Series, vol 17. New York: Raven Press, 1987.
6. Aaronson NK, van Dam FSAM, Polak CE, et al: Prospects and problems in European psychosocial oncology: A survey of the EORTC Study Group on Quality of Life. J Psychosoc Oncol 4:43-53, 1986
7. Ganz PA, Bernhard J, HOrny C: Quality of life and psychosocial oncology research in Europe: State of the art. J Psychosoc Oncol 9:122, 1991
8. Gelber RD, Goldhirsch A: A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4:1772-1779, 1986
9. Nayfield SG, Hailey BJ, eds: Quality of Life Assessment in Cancer Clinical Trials. Bethesda, Md: Division of Cancer Prevention and Control, NCI, 1991
10. American Cancer Society: American Cancer Society’s Second Workshop on Methodology in Behavioral and Psychosocial Cancer Research. Cancer 67 (suppl), 1991
11. Stiernsward J, Teoh N: Perspectives on quality of life and the global cancer problem. InEffect of Cancer on Quality of Life (Osoba D, ed). Boston: CRC Press, 1991, pp 1-5
12. Johnson JR, Temple R: Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:11551159, 1985
13. Henderson-James D, Spilker B: An industry perspective. InQuality of Life Assessment in Clinical Trials (Spilker B, ed). New York: Raven Press, 1990, pp 183-192
14. Kiebert GM, de Haes JC, van de Velde CJ: The impact of breast-conserving treatment and mastectomy on the quality of life of early-stage breast cancer patients: A review. J Clin Oncol 9:1059-1070, 1991
15. Irvine D, Brown B, Crooks D, et al: Psychosocial adjustment in women with breast cancer. Cancer 67:1097-1117, 1991.
16. Goldhirsch A, Gelber RD, Simes RJ, et al: Costs and benefits of adjuvant therapy in breast cancer: A quality-adjusted survival analysis. J Clin Oncol 7:36-44, 1989
17. Coates A, Gebski V, Bishop JF, et al: Improving the quality of life during chemotherapy for advanced breast cancer. A comparison of intermittent and continuous treatment strategies. N Engl J Med317:1490-1495, 1987
18. van Holten-Verzantvoort AT, Zwinderman AH, Aaronson NK, et al: The effect of supportive pamidronate treatment on aspects of quality of life of patients with advanced breast cancer. Eur J Cancer27:544-549, 1991
19. Geddes DM, Dones L, Hill E, et al: Quality of life during chemotherapy for small cell lung cancer: Assessment and use of a daily diary card in a randomized trial. Eur J Cancer 26:484-492, 1990.
20. Ganz PA, Lee JJ, Siau J: Quality of life assessment: An independent prognostic variable for survival in lung cancer. Cancer 67:3131-3135, 1991
21. Suoarbaker PH, Barofsky I, Rosenbero SA, et al: Quality of life assessment of patients in extremity sarcoma clinical trials. Surgery91:17-23, 1982
22. Veldhuyzen Van Zanten SJ: Quality of life as outcome measures in randomized clinical trials. An overview of three general medical journals. Controlled Clin Trials 12:234S-242S, 1991.
23. O’Youno J, McPeek B: Quality of life variables in surgical trials. J Chronic Dis 40:513-522, 1987
24. Deyo RA, Patrick DL: Barriers to the use of health status measures in clinical investigation, patient care, and policy research. Med Care27:S254-268, 1989
25. Yancik R, Edwards BK, Yates JW: Assessing the quality of life of cancer patients: Practical issues in study implementation. J Psychosoc Oncol 7:59-74, 1989
26. Cell a DF, Tulsky DS: Measuring quality of life today: Methodological aspects. Oncology (Williston Park) 4:29-38, 1990.
27. van Knippenberg FC, de Haes JC: Measuring the quality of life of cancer patients: Psychometric properties of instruments. J Clin Epidemiol 41:1043-1053, 1988
28. Osoba D, Aaronson NK, Till JE: A practical guide for selecting quality of life measures in clinical trials and practice. In Effect of Cancer on Quality of Life (Osoba D, ed). Boston: CRC Press, 1991, 89-104
29. Ware JE Jr: Methodology in behavioral and psychosocial cancer research. Conceptualizing disease impact and treatment outcomes. Cancer 53:2316-2326, 1984
30. Ware JE Jr, Brook RH, Davies-Avery A, et al: Conceptualization and Measurement of Health of Adults in the Health Insurance Study, Vol 1: Model of Health and Methodology. Santa Monica, Calif: Rand Corporation, 1980
31. Priestman TJ, Baum M: Evaluation of quality of life in patients receiving treatment for advanced breast cancer. Lancet 1:899-900, 1976
32. Schipper H, Clinch J, McMurray A, et al: Measuring the quality of life of cancer patients: The Functional Living Index—Cancer: Development and validation. J Clin Oncol 2:472-483, 1984.
33. Aaronson NK, Bullinger M, Ahmedzai S: A modular approach to quality-of-life assessment in cancer clinical trials. Recent Results Cancer Res 111:231-249, 1988
34. i Aaronson NK, Ahmedzai S, Bullinger M, et al: The EORTC Core Quality of Life Questionnaire: Interim results of an international field study. InEffect of Cancer on Quality of Life (Osoba D, ed). Boston: CRC Press, 1991, pp 185-203.
35. Schipper H, Clinch J, Powell V: Definitions and conceptual issues. In Quality of Life Assessment in Clinical Trials (Spilker B, ed). New York: Raven Press, 1990, pp 11-24.
36. Aaronson NK, Barker W, Stewart AL, et al: Multidimensional approach to the measurement of quality of life in lung cancer clinical trials. In The Quality of Life of Cancer Patients (Aaronson NK, Beckmann J, eds). New York: Raven Press, 1987, pp 63-82.
37. Zubrod CG, Scheiderman M, Frei E, et al: Cancer—appraisal of methods for the study of chemotherapy of cancer in men: Thiophosphoramide. J Chronic Dis 11:7-33, 1960.
38. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Geneva: WHO Offset Publ 48, 1979.
39. Ware JE, Davies-Avery A, Brook RH: Conceptualization and Measurement of Health for Adults in the Health Insurance Study: vol VI, Analysis of Relationships Among Health Status Measures. Santa Monica, Calif: Rand Corporation (publ No. 1978/2-HEW), 1978.
40. Hays RD, Hayashi T, Carson S, et al: User’s Guide for the Multitrait Analysis Program (MAP). Santa Monica, Calif: Rand Corporation, 1988
41. Hays RD, DiMatteo MR: A short-form measure of loneliness. J Pers Assess 51:69-81, 1987
42. Stewart AL, Hays RD, Ware JE Jr: The MOS short-form general health survey: Reliability and validity in a patient population. Med Care 26:724-735, 1988
43. Wu AW, Rubin HR, Mathews WC, et al: A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care29:786-798, 1991
44. Cronbach U: Coefficient alpha and the internal structure of tests. Psychometrika 16:297, 1951
45. Nunnally JC: Psychometric Theory, 2nd ed. New York: McGrawHill, 1978
46. Kerlinger FN: Foundations of Behavioral Research. New York: Holt, Rinehart & Winston, 1973
47. Guyatt G, Walter S, Norman G: Measuring change over time: Assessing the usefulness of evaluative instruments. J Chronic Dis40:171-178, 1987
48. Hays RD, Hadorn D: Responsiveness to change: An aspect of validity, not a separate dimension. Quality of Life Res 1:73-75, 1992.
49. Cohen J: Statistical Power Analysis for the Behavioral Sciences. New York: Academic Press, 1969
50. Ganz PA, Haskell CM, Figun RA, et al: Estimating the quality of life in a clinical trial of patients with metastatic lung cancer using the Karnofsky performance status and the Functional Living Index— Cancer. Cancer 61:849-856, 1988
51. Finkelstein DM, Cassileth BR, Bonomi PD, et al: A pilot study of the Functional Living Index—Cancer (FLIC) Scale for the assessment of quality of life for metastatic lung cancer patients. An Eastern Cooperative Oncology Group study. Am J Clin Oncol 11:630-633, 1988
52. Schao CA, Ganz PA, Heinrich RL: Cancer Rehabilitation Evaluation System—Short Form (CARES-SF): A cancer specific rehabilitation and quality of life instrument. Cancer 68:1406-1413, 1991.
53. Ganz PA, Schao CA, Lee JJ, et al: The CARES: A generic measure of health-related quality of life for patients with cancer. Quality of Life Res 1:19-29, 1992
54. de Haes JC, van Knippenberg FC, Neut JP: Measuring psychological and physical distress in cancer patients: Structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62:1034-1038, 1990
55. Wood-Dauphinee S, Williams JI: The Spitzer Quality of Life Index: Its performance as a measure. InEffect of Cancer on Quality of Life (Osoba D, ed). Boston: CRC Press, 1991, pp 169-184.
56. Cella DF, Tulsky DS, Bonomi A, et al: The Functional Assessment of Cancer Therapy (FACT) scales: Incorporating disease-specificity and subjectivity into quality of life (QL) assessment. Proc ASCO 9:307, 1990
57. Levine MN, Guyatt GH, Gent M, et al: Quality of life in stage II breast cancer: An instrument for clinical trials. J Clin Oncol 6:1798-1810, 1988
58. Ware JE Jr, Sherbourne CD: The MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual framework and item selection. Med Care 30:473-483, 1992
59. McHorney CA, Ware JE, Rogers W, et al: The validity and relative precision of MOS Short and Long Form Health Status Scales and Dartmouth COOP Charts: Results from the Medical Outcomes Study. Med Care 30 (suppl):253-265, 1992